Skip to main content
Inventiva logo

Inventiva — Investor Relations & Filings

Ticker · IVA ISIN · FR0013233012 LEI · 969500I9Y690B3FZW590 PA Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2025-08-12 Major Shareholding Noti…
Country FR France
Listing PA IVA

About Inventiva

https://inventivapharma.com/

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas include fibrotic diseases, lysosomal storage disorders, and oncology. Its lead product candidate, lanifibranor, is a pan-PPAR (peroxisome proliferator-activated receptor) agonist being evaluated in a pivotal Phase III clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). Lanifibranor is designed to address the key features of NASH, including steatosis, inflammation, ballooning, and fibrosis. The candidate has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) based on positive Phase IIb results.

Recent filings

Filing Released Lang Actions
Franchissement de seuil
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding levels (crossing the 5% threshold) by J.P. Morgan Chase & Co. in the company INVENTIVA. This is a standard regulatory disclosure required under Article L. 233-7 of the French Commercial Code, which corresponds to the 'Major Shareholding Notification' category.
2025-08-12 French
Franchissements de seuil
Major Shareholding Notification Classification · 100% confidence The document is an official notice from the AMF (Autorité des marchés financiers) regarding 'Déclarations de franchissement de seuil' (threshold crossing declarations). It details J.P. Morgan Chase & Co.'s acquisition and subsequent reduction of shareholdings in the company INVENTIVA, crossing the 5% threshold. This is a standard regulatory notification for major shareholding changes.
2025-08-12 French
Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
Regulatory Filings Classification · 95% confidence The document is a press release announcing the company's participation in an upcoming investor conference (Canaccord Genuity 45th Annual Growth Conference). It provides details about the event, the speakers, and the topics to be discussed. Since it does not fit into specific categories like earnings releases, financial reports, or governance filings, and serves as a general corporate announcement regarding investor relations activities, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate announcements.
2025-08-11 English
Inventiva Participera à la « Canaccord Genuity 45th Annual Growth Conference »
Regulatory Filings Classification · 95% confidence The document is a press release announcing that company executives will participate in a 'fireside chat' at the Canaccord Genuity 45th Annual Growth Conference. It provides details about the event, the speakers, and the topics to be discussed (R&D updates, clinical trials, and strategy). Since this is a general corporate announcement regarding an upcoming investor-facing event that does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2025-08-11 French
Franchissement de seuil
Major Shareholding Notification Classification · 100% confidence The document is an official notice from the Autorité des marchés financiers (AMF) regarding 'Déclarations de franchissement de seuil' (threshold crossing declarations) for the company INVENTIVA. It details J.P. Morgan Chase & Co.'s acquisition and subsequent reduction of shareholdings above the 5% threshold. This is a classic major shareholding notification, which corresponds to the MRQ filing category.
2025-08-11 French
Franchissement de seuil
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding levels (crossing a threshold) for the company INVENTIVA, filed in accordance with Article L. 233-7 of the French Commercial Code. It details that J.P. Morgan Chase & Co. has crossed below the 5% voting rights threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-08-11 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.